Vasopeptidase inhibition and angio-oedema.
Messerli
F H
FH
Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA 70121, USA.
Nussberger
J
J
D000799:Angioedema / Q000139:chemically induced*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D017706:Lisinopril / Q000009:adverse effects* / Q000627:therapeutic use; D015260:Neprilysin / Q000037:antagonists & inhibitors*; D016017:Odds Ratio; D011379:Prognosis; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D013841:Thiazepines / Q000009:adverse effects* / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D011725:Pyridines; D013841:Thiazepines; C106266:omapatrilat; D017706:Lisinopril; D015260:Neprilysin